Serial 98296993
Live / Registered — Registered (as of 18 Feb 2025)
What this means for you
Registered since 18 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98296993
- Registration number
- 7692621
- Mark type
- Design / logo
- Filed
- 04 Dec 2023
- Published for opposition
- 31 Dec 2024
- Registered
- 18 Feb 2025
- Attorney of record
- Sam Yip
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes, namely, anticancer medicines, antiinfection medicines, anti-inflammation medicines; Chinese medicine, namely, medicines made of Chinese traditional medicinal herbs; Western medicine, namely, pharmaceutical products for the treatment of cancer, infection, inflammation; Pharmaceutical preparations for the treatment of cancer, infection, inflammation; Biological preparations for use in cell cultures for medical purposes; Chemico-pharmaceutical preparations for oncology or immunology use; Chemico-pharmaceutical preparations for medical purposes, namely biological agents for the treatment of cancer, autoimmune disease; Biological reagent for medical purposes; Diagnostic test reagent for medical or veterinary purposes; Nutritional supplements; Freeze-dried food adapted for medical purposes; Enzyme nutritional supplements; Dietetic substances adapted for medical use; Herbal extract nutritional supplements; Plant extract nutritional supplements; Vitamin nutritional supplements; Pesticide
Owner
- ASCENDO BIOTECHNOLOGY CO., LTD., Taipei City, TW
- ASCENDO BIOTECHNOLOGY CO., LTD., Taipei City, TW
- ASCENDO BIOTECHNOLOGY CO., LTD., Taipei City, TW
Prosecution history
- 18 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Nov 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 28 Oct 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 28 Oct 2024 — LETTER OF SUSPENSION E-MAILED
- 28 Oct 2024 — SUSPENSION LETTER WRITTEN
- 26 Oct 2024 — EXAMINER'S AMENDMENT ENTERED
- 26 Oct 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 26 Oct 2024 — EXAMINERS AMENDMENT E-MAILED